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Introduction Goals Results 
Chloropyramine is a first generation 
antihistamine drug approved in some 
Eastern European countries for the 
treatment of allergic conjunctivitis, 
allergic rhinitis, bronchial asthma, and 
other allergic conditions . 
Chloropyramine is known as a 
competitive reversible H1-receptor 
antagonist. By blocking the effects of 
histamine, the drug inhibits the 
vasodilatation, increased vascular 
permeability, and tissue edema 
associated with histamine release in 
the tissue . 
 
 
 
 
Commercially available samples, 
Suprastin® for oral use containing 25 
mg chloropyramine in the form of 
chloropyramine hydrochloride were 
used in this study.  In addition to the 
active ingredient, each tablet contains 
stearic acid, gelatine, sodium 
carboxymethyl starch (type A) talc, 
potato starch, and lactose 
monohydrate. Chloropyramine 
hydrochloride purity ≥ 99.8% was 
obtained from Fluka, Germany. 
Chloropyramine base purity ≥99.7% 
was obtained from Alkaloid, 
Macedonia. 
Chloroform (Merck, Germany) gas 
chromatography grade was used for 
the extraction and preparation of 
standard solutions. Ammonium 
hydroxide (25%, V/V) was obtained 
from Fluka, Germany. Hydrochloric 
acid (37%, V/V) was obtained from 
Sigma Aldrich, Germany. Anhydrous 
sodium sulfate was obtained from 
Merck, Germany. Water was obtained 
by double distillation. 
 
 
 
 
 
The aim of this study was 
to develop a simple, 
rapid, specific, precise 
and accurate method 
based on GC-MS 
technique for the 
determination of 
chloropyramine 
hydrochloride in tablets. 
The method was 
validated in respect of 
system suitability, 
specificity, linearity 
range, accuracy, 
precision, limit of 
detection (LOD), limit of 
quantification (LOQ), 
selectivity, robustness 
and stability . 
System suitability  
 
 
 
 
 
 
 
 
Linearity and range 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The proposed GC-MS method allows a simple, accurate, precise and rapid 
determination of chloropyramine API in tablets. Furthermore, operating in SIM 
mode provides additional selectivity of the method in terms of interferences. 
The proposed method could be applicable for routine analysis in pharmaceutical 
analytical laboratories. 
Materials and  
methods 
Conclusions 
Parameter Results Parameter limit 
RSD of retention time 0.12% <1% 
RSD of peak area 0.25% <1% 
Capacity factor k, 5.52 >2% 
Theoretical plate 12,345 >2000 
Parameter Chloropyra
minea API 
Chloropyrami
ne 
+ excipients 
Linearity range 
(μg/L) 
0.4 – 4.0 0.8 – 8.0 
Slope 11178 11454 
Intercept 32 65 
Determination 
coefficient (r2) 
0.9999 0.9999 
SEb of the 
intercept 
29.432 24.332 
SE of the slope 65.433 71.343 
P – value of the 
slope 
0.395 0.386 
Precision Parameter % of declared 
content (X) 
RSD (%) Bias (%) 
Intra – assay 
precisiona 
25 mg tablets 99.75 0.75 0.25 
Day 1 96.15 0.95 3.85 
Intermediate 
precisiona 
Day 2 96.45 0.88 3.55 
Day 3 96.58 0.93 3.42 
X 96.39 0.10 3.60 
Amount added  
(μg/L) 
Amount found 
(μg/L) 
Recovery (%) RSD (%) Bias (%) 
 
0.402 
0.553       
0.617                         
 
0.398 
0.572                            
0.612 
 
 99.00 
103.44 
 99.19 
 
0.75 
1.05 
0.98 
0.99 
3.43 
0.81 
0.720      
0.795   
0.855                        
0.715 
0.790 
0.847 
 99.30 
 99.37 
 99.06 
0.95 
0.66 
0.78 
0.69 
0.63 
0.93 
X 99.89 0.15 0.105 
Accuracy 
